| Period Ending | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 |
|---|
|
Total Revenue
|
1,813,000
|
1,458,000
|
1,585,000
|
1,262,000
| | Cost of Revenue | 465,000 | 413,000 | 397,000 | 323,000 | | |
Gross Profit
|
1,348,000
|
1,045,000
|
1,188,000
|
939,000
| |
|
Operating Expenses |
|
Research Development | 344,000 | 293,000 | 297,000 | 244,000 |
|
Selling General and Administrative | 442,000 | 379,000 | 368,000 | 318,000 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
562,000
|
373,000
|
523,000
|
377,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (3,000) | (5,000) | (2,000) | 6,000 |
|
Earnings Before Interest And Taxes | 559,000 | 368,000 | 521,000 | 383,000 |
|
Interest Expense | 14,000 | 15,000 | 16,000 | 11,000 |
|
Income Before Tax | 545,000 | 353,000 | 505,000 | 372,000 |
|
Income Tax Expense | 212,000 | 134,000 | 441,000 | 431,000 |
|
Minority Interest | (1,000) | (2,000) | (21,000) | 21,000 |
|
|
|
Net Income From Continuing Ops | 332,000 | 217,000 | 43,000 | (38,000) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
332,000
|
217,000
|
43,000
|
(38,000)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
332,000
|
217,000
|
43,000
|
(38,000)
|
|
0.22 (0.44%) 7:24AM EDT - Nasdaq Real Time Price